Patents by Inventor Gero Miesenböck

Gero Miesenböck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220057384
    Abstract: The present invention relates to one or more ligands of a potassium channel ? subunit for use in therapy, and in particular for use in treating or preventing a sleep disorder in a subject. The invention also provides a method of screening a test compound to determine if it is a substrate of a potassium channel ? subunit.
    Type: Application
    Filed: October 19, 2019
    Publication date: February 24, 2022
    Inventors: Gero MIESENBOECK, Anissa KEMPF, Seoho SONG
  • Patent number: 7144733
    Abstract: Cells are rendered sensitive to stimulation by introducing into a non-photoreceptor cell nucleic acid sequences encoding at least an opsin gene product, an arrestin gene product, and the alpha subunit of the heterotrimeric G protein of the Gq family. The introduced sequences are expressed by the cell to yield at least the opsin gene product, the arrestin gene product, and the alpha subunit of the heterotrimeric G protein of the Gq family. Retinal or a derivative thereof capable of bonding with the opsin gene product to form a rhodopsin is provided to the cell. The cell is then irradiated with light having a wavelength capable of converting the rhodopsin to metarhodopsin. The conversion of rhodopsin to metarhodopsin triggers a cascade of intracellular responses within the cell resulting in an increased intracellular concentration of IP3 and calcium ions.
    Type: Grant
    Filed: August 16, 2002
    Date of Patent: December 5, 2006
    Assignee: Sloan-Kettering Institute for Cancer Research
    Inventors: Gero Miesenböck, Boris V. Zemelman
  • Patent number: 7094888
    Abstract: The invention relates to methods and compositions which utilize the emission of light to monitor changes in microenvironments involving cells. The invention is especially useful for monitoring exocytotic activity such as detecting quantal release of synaptic vesicles. Fusion proteins of Cypridina luciferase and synaptotagmin-I or VAMP/synaptobrevin-2 were targeted to synaptic vesicles and, upon exocytosis, formed light-emitting complexes with luciferin present in the extracellular medium. Photon emissions in the presence of a depolarizing stimulus can be observed with these systems. pH-sensitive mutants of green fluorescent protein are also provided, which are useful for visualizing exocytosis and for imaging and measuring the pH of intracellular compartments.
    Type: Grant
    Filed: September 30, 2003
    Date of Patent: August 22, 2006
    Assignee: Memorial Sloan-Kettering Cancer Center
    Inventors: Gero Miesenböck, Dino De Angelis, James E. Rothman
  • Patent number: 6804000
    Abstract: Method and apparatus for steering a beam of light. The method and apparatus are based on the discovery that the spectral dispersion of multi-chromatic light pulses by an acousto-optical deflector can be significantly ameliorated by positioning a dispersive element, such as a prism, along the path of the multi-chromatic light pulses in such a way that the dispersive element disperses the multi-chromatic light pulses in a direction opposite to the spectral dispersion caused by the acousto-optical deflector. The dispersive element may be positioned either before or after the acousto-optical deflector. The method and apparatus are particularly well-suited for use with ultrashort laser pulses in the visible and infrared ranges having a bandwidth of up to about 40 nm. The method and apparatus have applicability in, among other things, multi-photon laser scanning microscopy.
    Type: Grant
    Filed: December 14, 2001
    Date of Patent: October 12, 2004
    Assignee: Sloan-Kettering Institute for Cancer Research
    Inventors: Robert Dixon Roorda, Gero Miesenböck
  • Patent number: 6670449
    Abstract: The invention relates to methods and compositions which utilize the emission of light to monitor changes in microenvironments involving cells. The invention is especially useful for monitoring exocytotic activity such as detecting quantal release of synaptic vesicles. Fusion proteins of Cypridina luciferase and synaptotagmin-I or VAMP/synaptobrevin-2 were targeted to synaptic vesicles and, upon exocytosis, formed light-emitting complexes with luciferin present in the extracellular medium. Photon emissions in the presence of a depolarizing stimulus can be observed with these systems. pH-sensitive mutants of green fluorescent protein are also provided, which are useful for visualizing exocytosis and for imaging and measuring the pH of intracellular compartments.
    Type: Grant
    Filed: February 13, 1998
    Date of Patent: December 30, 2003
    Assignee: Memorial Sloan-Kettering Cancer Center
    Inventors: Gero Miesenböck, Dino De Angelis, James E. Rothman